Clinical Research Facility

Orangeburg, New York 10962

We've found

3 trials

at this facility

Efficacy and Safety Trial of Verubecestat (MK-8931) in Participants With Prodromal Alzheimer's Disease (MK-8931-019)

Status: Enrolling, Phase III
Updated: 8/10/2016

from

Orangeburg, NY

An Efficacy and Safety Trial of Verubecestat (MK-8931) in Mild to Moderate Alzheimer's Disease (P07738)

Status: Enrolling, Phase II, III
Updated: 10/22/2015

from

Orangeburg, NY

Efficacy and Safety of MK-7622 as Adjunct Therapy in Participants With Alzheimer's Disease (MK-7622-012)

Status: Enrolling, Phase II
Updated: 2/25/2016

from

Orangeburg, NY

Use our guide to learn which trials are right for you!